Dare Bioscience Inc DARE

US Pharmaceuticals

$1.22 ▼ -1.61% ($-0.02)

🗓️ Earnings Next Week

Open $1.24

Prev Close $1.24

Day Range $1.21 – $1.27

52W Range $1.13 – $3.78

Market Cap $18.27M

Beta 1.07

EPS (TTM) $-0.59

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2014-04-10
Shares Out.	14,980,000
Website	darebioscience.com/ ↗
Phone	18589267655
Employees	24
Revenue	$152,455
Gross Profit	-$89,870
Net Income	-$3.0M
Free Cash Flow	-$10.2M
Total Assets	$27.8M
Total Liabilities	$27.1M
Equity	$734,451

About Dare Bioscience Inc

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Dare Bioscience Inc is a publicly traded company under the ticker symbol DARE on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.